Abstract
We measured immunity to type II collagen and proteoglycans in osteoarthritic C57BL mice to determine whether it is related to osteoarthritis pathogenesis. Histological examination revealed articular cartilage lesions in all mice and synovitis in only a few mice. Immunological responses to type II collagen were found in collagen arthritic mice, but not in C57BL mice. Furthermore, immunological responses to proteoglycans were observed in proteoglycan-immunized mice, but not in C57BL mice. Therefore, articular cartilage degeneration may not result in autoimmunity to type II collagen and proteoglycans in osteoarthritis of C57BL mice, and immune responses to these components may not be a primary etiology of osteoarthritis in this model.
Similar content being viewed by others
References
Sokoloff L. Aging and degenerative diseases affecting cartilage. In Cartilage, ed. B. Hall. Vol. III. New York 1983: Academic Press: 109–41.
Howell DS. Pathogenesis of osteoarthritis. Am J Med 1986;80:24–8.
Champion BR, Poole AR. Immunity to homologous type III collagen after partial meniscectomy and sham surgery in rabbits. Arthritis Rheum 1982;25:274–85.
Goldberg VM, Kresina TF. Immunology of articular cartilage. J Rheumatol (suppl 14) 1987;14:73–6.
Moskowitz RW, Kresina TF. Immunofluorescent analysis of experimental osteoarthritic cartilage and synovium: Evidence for selective deposition of immunoglobulin and compliment in cartilaginous tissues. J Rheumatol 1986;13:391–6.
Niebauer GW, Wolf B, Bashey RI, Newton C. Antibodies to canine collagen types II and III in dogs with spontaneous cruciate ligament rupture and osteoarthritis. Arthritis Rheum 1987;30:319–27.
Stuart JM, Postlethwaite AE, Townes AS. Cell mediate immunity to collagen and collagen chains in rheumatoid arthritis and other rheumatic disease. Am J Med 1980;69:13–8.
Silberberg M, Silberberg R. Age changes of bones and joints in various strains of mice. Am J Anat 1941;68:69–95.
Faltz LL, Reddi AH, Hascall GK, Martin D, Pita JC, Hascall VC. Characteristics of proteoglycans extracted from the swarm rat chondrosarcoma with associative solvents. J Biol Chem 1979;254:1375–80.
Bitter T, Muir H. A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330–4.
Mikecz K, Glant T, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987;30:306–18.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano EK, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76–85.
Takagishi K, Kaibara N, Hotokebuchi T, Arita C, Morinaga M, Arai K. Effect of cyclosporin on collagen-induced arthritis in mice. Ann Rheum Dis 1986;45:331–44.
Voller A, Bidwell DE, Bartlett A. Enzyme immunoassays in diagnostic medicine: theory and practice. Bull WHO 1976;53:55–65.
Cremer MA, Hernandez AD, Townes AS. Collagen-induced arthritis in rats: antigen specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol 1983;131:2995–3000.
Takagishi K, Yamamoto M, Nishimura A, Yamasaki G, Kanazawa N, Hotokebuchi T, et al. Effects of FK-506 on collagen arthritis in mice. Transplant Proc 1989;21:1053–5.
Wilhelmi G. Effect of C21, 524-Su(pirprofen) on spontaneous osteoarthritis in the mouse. Pharmacol 1978;16:268–72.
Steffen C, Timpl R, Wolff I. Immunogenicity and specificity of collagen. V. Demonstration of three different antigenic determinants on calf collagen. Immunol 1968;15:135–44.
Timpl R, Wolff I, Furthmayr H. Immunogenicity and specificity of collagen. VI. Separation of antibody fractions with restricted specificity from anti-collagen sera using an immunoadsorbent technique. Immunol 1968;15:145–51.
Moreland LW, Stewart T, Gay RE, Huang GQ, McGee N, Gay S. Immunohistologic demonstration of type II collagen in synovial fluid phagocytes of osteoarthritis and rheumatoid arthritis patients. Arthr Rheum 1989;32:1458–64.
Rowley MJ, Williamson JD, Mackay IR. Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthr Rheum 1987;30:1420–5.
Choi EK, Gatenby PA, McGill NW, Bateman JF, Cole WG, York JR. Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis 1988;47:313–22.
Clague RB, Morgan K, Collins I, Pattrick M, Doherty M. Absence of autoimmunity to type II collagen in generalised nodal osteoarthritis. Ann Rheum Dis 1991;50:769–71.
Harmann DJ, Charriere G, Ville G, Vignon E, Bejui J. Absence of antibodies to native type I and type II collagen in a rabbit model of osteoarthritis. Arthritis Rheum 1988;32:814–5.
Baxer E, Muir H. The antigenicity of cartilage proteoglycans: The relationship of the antigenic determinants present in Smith degraded and intact proteoglycans. Biochim Biophys Acta 1972;279:276–81.
Di Ferrante N, Donnelly PV, Gregory JD, Sajdera SW. Antigenic determinants of two components of proteoglycan complex from bovine cartilage. FEBS Lett 1970;9:149–51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takagishi, K., Maeda, K., Goso, Y. et al. Absence of immunity to type II collagen and proteoglycan in osteoarthritic C57BL mice. Inflamm Res 44, 222–226 (1995). https://doi.org/10.1007/BF01782263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01782263